StonvexLoading…
StonvexStonvexStonvexCore line items from UPBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.70B | $4.32B | $3.99B | $4.25B |
Operating Income | $223.35M | $291.63M | $162.87M | $148.54M |
Net Income | $73.24M | $123.48M | $-5.18M | $12.36M |
EPS (Diluted) | $1.25 | $2.21 | $-0.09 | $0.21 |
Total Assets | $3.28B | $2.65B | $2.72B | $2.76B |
Total Liabilities | $2.58B | $2.02B | $2.16B | $2.24B |
Cash & Equivalents | $120.53M | $60.86M | $93.70M | $144.14M |
Free Cash Flow OCF − CapEx | $238.71M | $48.45M | $146.89M | $407.07M |
Shares Outstanding | 58.61M | 55.93M | 54.98M | 58.97M |